This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Lucira Health Valuation

Is LHDX.Q undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Share Price vs Fair Value

What is the Fair Price of LHDX.Q when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for LHDX.Q?

Key metric:

The above table shows the Price to Sales ratio for LHDX.Q. This is calculated by dividing LHDX.Q's market cap by their current revenue.
What is LHDX.Q's PS Ratio?
PS Ratio	0.00002x
Sales	US$212.13m
Market Cap	US$4.18k

LHDX.Q key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.04x
Enterprise Value/EBITDA	-0.06x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does LHDX.Q's PS Ratio compare to its peers?

The above table shows the PS ratio for LHDX.Q vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	0.7x
FORZ Forza Innovations	2.8x	n/a	US$264.8k
THMO ThermoGenesis Holdings	0.001x	n/a	US$11.1k
VRAY.Q ViewRay	0.0002x	n/a	US$18.3k
MOTS Motus GI Holdings	0.004x	n/a	US$1.4k
LHDX.Q Lucira Health	0.00002x	n/a	US$4.2k

Price to Sales Ratio vs Industry

How does LHDX.Q's PS Ratio compare vs other companies in the US Medical Equipment Industry?

49 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	3.5x	8.2%
LHDX.Q Lucira Health	0.00002x	n/a	US$4.18k
VREX Varex Imaging	0.7x	2.3%	US$573.52m
INGN Inogen	0.8x	4.4%	US$266.53m

49 Companies		Estimated Growth	Market Cap
Industry Avg.	3.5x	16.6%
LHDX.Q Lucira Health	0.00002x	n/a	US$4.18k

No more companies

Price to Sales Ratio vs Fair Ratio

What is LHDX.Q's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LHDX.Q PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.00002x
Fair PS Ratio	n/a

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Discover undervalued companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/10/04 13:19
End of Day Share Price	2023/10/04 00:00
Earnings	2022/09/30
Annual Earnings	2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lucira Health, Inc. is covered by 3 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Derik de Bruin	BofA Global Research
David Sherman	LifeSci Capital, LLC
Brian Weinstein	William Blair & Company L.L.C.